Few health stories have moved as fast as the rise of GLP-1 weight-loss medications. In the space of a few years, drugs with names like Ozempic, Wegovy, Saxenda and Mounjaro have gone from specialist diabetes clinics to kitchen-table conversations. If you are in your fifties, sixties or seventies and carrying weight you would rather not be carrying, you have almost certainly wondered whether these injections are worth a conversation with your GP.
They might be. But the picture for older adults is genuinely different from the one you see in headlines and social media adverts, and the differences matter. Here is what the evidence actually says, what these medications cost in Ireland right now, and the questions worth asking before you start.
TL;DR
- GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) work by slowing digestion and reducing appetite signals in the brain. They are prescription-only medicines, not lifestyle products.
- In Ireland, liraglutide (Saxenda) is currently the only weight-management GLP-1 reimbursed by the HSE, and only under a strict Managed Access Protocol. Wegovy and Mounjaro are private prescriptions costing roughly €220 to €330 a month.
- Between 15% and 40% of the weight lost on these medications can be lean tissue, including muscle. After 50, when muscle is already declining, that makes resistance exercise and adequate protein essential rather than optional.
- The HPRA has repeatedly warned about falsified semaglutide sold online. There is no authorised powder or generic version of semaglutide, so any product sold that way is fake.
- Tell every clinician you see, including anaesthetists and dentists, that you are taking a GLP-1 medication. It changes how your stomach empties and interacts with several common prescriptions.
What these medications actually do
GLP-1 is a hormone your gut releases after eating. It tells your pancreas to produce insulin, slows the rate at which food leaves your stomach, and signals fullness to the brain. GLP-1 receptor agonists are synthetic versions that stay active far longer than the natural hormone, usually given as a once-weekly injection.
The practical effect is that you feel full sooner, stay full longer, and think about food less. Trial data has been striking: semaglutide at weight-management doses produced average weight loss around 15% of body weight over 68 weeks, and tirzepatide has performed even better in head-to-head comparisons. For people whose weight is driving type 2 diabetes, sleep apnoea, joint pain or cardiovascular risk, that can be genuinely life-changing.
What you will actually pay in Ireland
This is where expectations often meet reality. As of 2026, liraglutide (Saxenda) remains the only weight-management GLP-1 reimbursed through the Drugs Payment Scheme or Medical Card, and access runs through a Managed Access Protocol with tight criteria: a BMI of 35 or above alongside prediabetes and high cardiovascular risk, with a requirement to demonstrate at least 5% weight loss after twelve weeks on the full dose to continue.
Wegovy has been under assessment by the National Centre for Pharmacoeconomics, but there is no confirmed reimbursement date. Mounjaro and Ozempic are not covered for weight management. In practice, that means a private prescription and roughly €220 to €330 per month at full dose, indefinitely. Reimbursement decisions do change, so it is worth asking your pharmacist about current status rather than relying on what you read last year.
Ozempic deserves a specific note: it is licensed in Ireland for type 2 diabetes, not for weight loss. Prescribing it off-label for weight management has contributed to supply pressures for people who need it to manage their diabetes.
The muscle question, and why it matters more after 50
This is the part most coverage skips, and it is the part that should shape your decision most if you are over 50.
When you lose weight through any method, you lose some muscle along with fat. On GLP-1 medications, studies suggest lean body mass accounts for somewhere between 15% and 40% of total weight lost. In a healthy 35-year-old, that is manageable. After 50, you are already losing muscle mass at a background rate of roughly 1% a year, and low muscle mass in later life is directly linked to falls, frailty, longer hospital stays and loss of independence.
The research is genuinely mixed rather than alarming. Some shorter trials found grip strength was preserved even as lean tissue fell. A twelve-month study of semaglutide actually found sarcopenic obesity became less common, dropping from 49% of participants to 33%. But longer retrospective work in older adults with type 2 diabetes has reported accelerated muscle decline and reduced grip strength, particularly at higher doses and in people who already had low muscle mass.
The sensible reading is not “avoid these medications”. It is that if you take one after 50, resistance training and protein intake stop being general good advice and become part of the treatment. Aim for two or three sessions a week of resistance work, whether that is bands, weights or bodyweight exercise, and roughly 1.0 to 1.2 grams of protein per kilogram of body weight daily, spread across meals rather than loaded into dinner. That last part is harder than it sounds when a medication has suppressed your appetite, which is exactly why a referral to a CORU-registered dietitian is worth requesting rather than waiting to be offered.
Side effects worth knowing about
Nausea, constipation and reflux are common, particularly during dose escalation, and usually settle. Less common but more serious risks include gallstones (rapid weight loss is itself a risk factor), pancreatitis and dehydration, the last of which matters more after 50 because thirst signals weaken with age and dehydration can affect kidney function.
Interactions are the underrated issue. If you take insulin or a sulfonylurea such as gliclazide, adding a GLP-1 raises hypoglycaemia risk and your doses may need adjusting. Because these drugs slow gastric emptying, they can alter how other oral medicines are absorbed. And before any procedure requiring sedation or general anaesthetic, tell the team: current guidance often involves pausing GLP-1 medication beforehand, because a stomach that has not emptied properly increases aspiration risk. Your community pharmacist is well placed to run a medication review and flag any of this.
Do not buy these online
The Health Products Regulatory Authority has been consistent and blunt about this. Detentions of falsified semaglutide products have risen sharply, from 32 units in a full year to hundreds in a matter of months, and seized products have included vials of unidentified powder and pens marketed as generic semaglutide. The HPRA’s position is clear: there is no authorised powder form and no authorised generic version of semaglutide, so anything sold that way is counterfeit by definition. People have been hospitalised elsewhere in Europe after using falsified pens, in some cases because the pen contained insulin.
Questions worth bringing to your GP
Rather than asking whether you can have the injection, try asking what problem you are trying to solve. Is it a diabetes risk, a knee that will not tolerate your current weight, sleep apnoea, or how you feel about yourself? The answer shapes whether medication is the right tool at all.
Then ask practically: what is the plan for protecting muscle, what happens to my other prescriptions, how long am I expected to stay on this, and what happens when I stop? That last one matters. Trial follow-up data shows most weight is regained within a year or two of stopping, which means these are best understood as long-term treatments for a chronic condition rather than a course you finish.
None of this is an argument against GLP-1 medications. For the right person, they are among the most effective tools we have. It is an argument for going in with clear eyes, a strength routine, a decent protein plan, and a GP who knows the whole picture. At Críonna Health we keep coming back to the same principle: the goal after 50 is not simply a smaller number on the scales, it is more years of moving well and living independently. Choose the approach that serves that.
This article is for general information and is not a substitute for medical advice. Talk to your GP or pharmacist about your own circumstances.
📷 Photo by Jason Briscoe on Unsplash
